Back to comparisons

Comparison

Rhodiola Rosea vs Polygala (Yuan Zhi)

FieldRhodiola RoseaPolygala (Yuan Zhi)
Categoryadaptogenadaptogen
Dose range200–400mg200–600mg
Half-life4h
Onset
EvidenceEVIDENCEAEVIDENCEC
Safety●●●●●●●●●
Legal (US)USOTCUSOTC
PubMed refs460280

The comparison in plain English

Auto-generated from data

Rhodiola Rosea and Polygala (Yuan Zhi) are both in the adaptogen category respectively. Rhodiola Rosea An Arctic adaptogen used for centuries in Siberian, Scandinavian, and Tibetan traditional medicine. Polygala (Yuan Zhi) Chinese herb (Polygala tenuifolia) traditionally used for memory, sleep, and emotional balance.

Bottom line

Rhodiola Rosea (evidence A, safety 5/5) has a weaker evidence base than Polygala (Yuan Zhi) (evidence C, safety 4/5). Rhodiola Rosea has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Rhodiola Rosea if

Rhodiola Rosea is the better fit when your goal aligns with its mechanism (Rosavins and salidroside (the two standardised active compounds) modulate the HPA axis cortisol response under acute stress) and the dose range (200–400mg) suits your protocol. Half-life is 4h.

Choose Polygala (Yuan Zhi) if

Polygala (Yuan Zhi) is the better fit when your goal aligns with its mechanism (Tenuifolin and onjisaponin B inhibit acetylcholinesterase) and the dose range (200–600mg) suits your protocol. Half-life is —h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →